Clinical Trial: A Randomized Clinical Trial of Antiplatelets in Psoriasis

U.S., Aug. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07744191) titled 'A Randomized Clinical Trial of Antiplatelets in Psoriasis' on July 29.

Brief Summary: The purpose of this study is to determine the effect of antiplatelet therapy on the endovascular phenotype in psoriasis, specifically whether clopidogrel reduces vascular endothelial pro-atherosclerotic transcript expression more than aspirin or placebo. The primary endpoint is mean change in a composite endothelial pro-inflammatory/pro-atherosclerotic transcript expression signature measured from brachial vein endothelial cells.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Psoriasis (PsO) Psoriatic Arthritis (PsA)

Interv...